Twinbeech Capital LP Bio Techne Corp Transaction History

Twinbeech Capital LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $1.03 Million - $1.4 Million	-16,610 Reduced 19.43%	68,876 $4.93 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $5.64 Million - $6.59 Million	85,486 New	85,486 $6.02 Million
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $3.41 Million - $4.51 Million	50,448 New	50,448 $3.43 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $1.23 Million - $1.49 Million	17,213 New	17,213 $1.28 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $3.18 Million - $4.41 Million	-11,267 Reduced 40.83%	16,326 $4.64 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $8.9 Million - $12.4 Million	27,593 New	27,593 $9.57 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $679,962 - $886,429	-2,754 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $269,607 - $328,516	1,161 Added 72.88%	2,754 $682,000
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $295,389 - $445,339	1,593 New	1,593 $421,000
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $645,002 - $886,483	-4,002 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $759,099 - $888,804	4,002 New	4,002 $878,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.